Myeloablative Cord Blood Transplantation in Adults with Acute Leukemia: Comparison of Two Different Transplant Platforms

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 12, 2013, Pages 1725-1730

  Sanz, Jaime ^a   Wagner, John E ^b   Sanz, Miguel A ^a   DeFor, Todd ^b   Montesinos, Pau ^a   Bachanova, Veronika ^b   Lorenzo, Ignacio ^a   Warlick, Erica ^b   Sanz, Guillermo F ^a   Brunstein, Claudio ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Acute leukemia; UCB transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; FLUDARABINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; DOUBLE UNIT UMBILICAL CORD BLOOD TRANSPLANTATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MYELOABLATIVE CONDITIONING; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; RECURRENCE RISK; RETROSPECTIVE STUDY; SINGLE UNIT UMBILICAL CORD BLOOD TRANSPLANTATION; THROMBOCYTE COUNT; WHOLE BODY RADIATION;

ACUTE LEUKEMIA; UCB TRANSPLANTATION;

ADOLESCENT; ADULT; COHORT STUDIES; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887533484     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.09.015     Document Type: Article

References (37)

1. Eapen M., Rubinstein P., Zhang M.-J., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. The Lancet 2007, 369:1947-1954.
2. Eapen M., Rocha V., Sanz G.F., et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010, 11:653-660.
3. Brunstein C.G., Gutman J.A., Weisdorf D.J., et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 2010, 116:4693-4699.
4. Sanz J., Sanz M.A., Saavedra S., et al. Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia. Biol Blood Marrow Transplant 2010, 16:86-94.
5. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors. NEngl J Med 1998, 339:1565-1577.
6. Wagner J.E., Barker J.N., DeFor T.E., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002, 100:1611-1618.
7. Cornetta K., Laughlin M.J., Carter S.L., et al. Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT). Biol Blood Marrow Transplant 2005, 11:149-160.
8. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105:1343-1347.
9. Rocha V., Crotta A., Ruggeri A., et al. Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases. Best Pract Res Clin Haematol 2010, 23:223-229.
10. Sanz J., Boluda J.C.H., Martín C., et al. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen. Bone Marrow Transplant 2012, 47:1287-1293.
11. Sanz G.F., Saavedra S., Planelles D., et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001, 98:2332-2338.
12. Verneris M.R., Brunstein C.G., Barker J., et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 2009, 114:4293-4299.
13. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
14. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
15. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
16. Gooley T.A., Leisenring W., Crowley J., Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18:695-706.
17. Gray R.J. Aclass of K-sample tests for comparing the cumulative incidence of a competing risk. Annals Statistics 1988, 16:1141-1154.
18. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. JAmer Statistical Assoc 1958, 53:457-481.
19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
20. Cox D.R. Regression models and life tables (with discussion). JR Stat Soc B 1972, 34:187-220.
21. Fine J.P., Gray R.J. Aproportional hazards model for the subdistribution of a competing risk. JAmer Statistical Assoc 1999, 94:496-509.
22. R Core Team. R: A Language and Environment for Statistical Computing.2012.
23. Rocha V., Labopin M., Sanz G.F., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. NEngl J Med 2004, 351:2276-2285.
24. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. NEngl J Med 2004, 351:2265-2275.
25. Pidala J., Kim J., Perkins J., et al. Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease. Bone Marrow Transplant 2010, 45:919-924.
26. Okamura A., Shimoyama M., Ishii S., et al. Delayed neutrophil engraftment in cord blood transplantation with intensive administration of mycophenolate mofetil for GVHD prophylaxis. Bone Marrow Transplant 2011, 46:148-149.
27. Sanz J., Picardi A., Hernández Boluda J.C., et al. Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation. Biol Blood Marrow Transplant 2013, 19:1387-1392.
28. MacMillan M.L., Weisdorf D.J., Brunstein C.G., et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009, 113:2410-2415.
29. Walker C.M., van Burik J.A., De For T.E., Weisdorf D.J. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biol. Blood Marrow Transplant 2007, 13:1106-1115.
30. Montesinos P., Sanz J., Cantero S., et al. Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation. Biol. Blood Marrow Transplant 2009, 15:730-740.
31. Rodrigues C.A., Sanz G.F., Brunstein C.G., et al. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. JClin Oncol 2009, 27:256-263.
32. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007, 110:3064-3070.
33. Scaradavou A., Brunstein C.G., Eapen M., et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood 2013, 121:752-758.
34. Gluckman E., Rocha V., Arcese W., et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004, 32:397-407.
35. Atsuta Y., Kanda J., Takanashi M., et al. Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia. Haematologica 2013, 98:814-822.
36. Cohen Y.C., Scaradavou A., Stevens C.E., et al. Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant 2011, 46:70-76.
37. Arcese W., Rocha V., Labopin M., et al. Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica 2006, 91:223-230.